Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:808-813
Published online before print August 4, 2003, doi: 10.1161/01.CIR.0000084552.54277.64
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/7/808    most recent
01.CIR.0000084552.54277.64v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wakatsuki, A.
Right arrow Articles by Fukaya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wakatsuki, A.
Right arrow Articles by Fukaya, T.
Related Collections
Right arrow Lipid and lipoprotein metabolism

(Circulation. 2003;108:808.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Effect of Lower Dose of Oral Conjugated Equine Estrogen on Size and Oxidative Susceptibility of Low-Density Lipoprotein Particles in Postmenopausal Women

Akihiko Wakatsuki, MD; Yuji Okatani, MD; Nobuo Ikenoue, MD; Koichi Shinohara, MD; Kazushi Watanabe, MD; Takao Fukaya, MD

From the Department of Obstetrics and Gynecology, Kochi Medical School, Kochi, Japan.

Reprint requests to Akihiko Wakatsuki, MD, Department of Obstetrics and Gynecology, Kochi Medical School, Oko cho, Nankoku, Kochi, Japan 783-8505. E-mail wakatuki{at}kochi-ms.ac.jp

Received December 18, 2002; de novo received April 8, 2003; revision received May 28, 2003; accepted May 28, 2003.

Background— Estrogen replacement therapy (ERT) has an antioxidant effect that opposes the oxidation of LDL. Oral ERT-induced increases in plasma triglyceride, however, are associated with decreased LDL size, which may counteract this antioxidant effect. Because lower doses of oral estrogen do not affect plasma triglyceride concentrations, LDL size might not change, and the antioxidant effect of estrogen might be preserved. We investigated whether a lower dose of oral estrogen could eliminate the adverse effects of high-dose oral ERT on the size and oxidative susceptibility of LDL in postmenopausal women.

Methods and Results— Postmenopausal women received no treatment or were treated with oral conjugated equine estrogen (CEE) 0.625 or 0.3125 mg/d for 3 months. CEE at a dose of 0.625 mg/d significantly increased plasma triglyceride concentrations and decreased LDL diameter, but the concentrations of LDL-derived thiobarbituric acid reactive substances (TBARS) and lag time for conjugated diene formation did not change. In contrast, 0.3125 mg of CEE did not affect plasma triglyceride concentrations or LDL diameter and significantly decreased LDL-derived TBARS concentrations and significantly prolonged LDL lag time. Estrogen-induced changes in LDL diameter correlated negatively with changes in plasma triglyceride (r=-0.44, P<0.01) and LDL-derived TBARS (r=-0.57, P<0.001) but positively with changes in LDL lag time (r=0.42, P<0.01).

Conclusions— Because oral CEE at a dose of 0.3125 mg/d does not elevate plasma triglyceride, resulting in unchanged size of LDL particles that are resistant to oxidation, the antioxidant effect of estrogen can be preserved.


Key Words: lipoproteins • hormones • women




This article has been cited by other articles:


Home page
Hum ReprodHome page
J. Pincemail, S. Vanbelle, U. Gaspard, G. Collette, J. Haleng, J.P. Cheramy-Bien, C. Charlier, J.P. Chapelle, D. Giet, A. Albert, et al.
Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of Liege, Belgium
Hum. Reprod., August 1, 2007; 22(8): 2335 - 2343.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Wakatsuki, K. K. Koh, E. K. Shin, and I. Sakuma
Lower Doses of Estrogen Replacement Therapy and the Risk of Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): e197 - e197.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Wakatsuki, N. Ikenoue, K. Shinohara, K. Watanabe, and T. Fukaya
Effect of Lower Dosage of Oral Conjugated Equine Estrogen on Inflammatory Markers and Endothelial Function in Healthy Postmenopausal Women
Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 571 - 576.
[Abstract] [Full Text]


Home page
JWatch Women's HealthHome page
Lower-Dose Estrogen: Better Lipid and Oxidation Profile
Journal Watch Women's Health, October 22, 2003; 2003(1022): 2 - 2.
[Full Text]